FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/06/069257 [Registered on: 20/06/2024] Trial Registered Prospectively
Last Modified On: 19/06/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A clinical trial for assessment of Dexmedetomidine as an adjuvant to ropivacaine in ultrasound-guided Erector spinae plane block in paediatric abdominal surgeries. 
Scientific Title of Study   A randomized controlled trial to assess the efficacy of dexmedetomidine as an adjuvant to ropivacaine in ultrasound guided erector spinae plane block in paediatric abdominal surgeries. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Pooja Kumari Singh 
Designation  Junior Resident 
Affiliation  Aligarh Muslim University 
Address  Department of Anaesthesiology and Critical Care, Jawaharlal Nehru Medical College, AMU, Aligarh Uttar Pradesh 202002 India
Department of Anaesthesiology and Critical Care, Jawaharlal Nehru Medical College, AMU, Aligarh Uttar Pradesh 202002 India
Aligarh
UTTAR PRADESH
202002
India 
Phone  8789311383  
Fax    
Email  pooja.ngr25@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Farah Nasreen 
Designation  Assistant Professor 
Affiliation  Aligarh Muslim University 
Address  Department of Anaesthesiology and Critical Care, Jawaharlal Nehru Medical College, AMU, Aligarh Uttar Pradesh 202002 India
Department of Anaesthesiology and Critical Care, Jawaharlal Nehru MedicalCollege, AMU, Aligarh Uttar Pradesh 202002 India
Aligarh
UTTAR PRADESH
202002
India 
Phone  9897067670  
Fax    
Email  kazmifarah@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Pooja Kumari Singh 
Designation  Junior resident 
Affiliation  Aligarh Muslim University 
Address  Department of Anaesthesiology and Critical Care, Jawaharlal Nehru Medical College, AMU, Aligarh Uttar Pradesh 202002 India
Department of Anaesthesiology and Critical Care, Jawaharlal Nehru Medical College, AMU, Aligarh Uttar Pradesh 202002 India
Aligarh
UTTAR PRADESH
202002
India 
Phone  8789311383  
Fax    
Email  pooja.ngr25@gmail.com  
 
Source of Monetary or Material Support  
Department of Anaesthesiology and Critical Care,Jawaharlal Nehru Medical College AMU Aligarh 
 
Primary Sponsor  
Name  Department of Anaesthesiology and Critical Care Jawaharlal Nehru Medical College AMU Aligarh 
Address  Department of Anaesthesiology and Critical Care,Jawaharlal Nehru Medical College, AMU Aligarh 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Pooja Kumari Singh  Jawaharlal Nehru Medical College AMU Aligarh  Department of Anaesthesiology and Critical Care,Jawaharlal Nehru Medical College AMU Aligarh
Aligarh
UTTAR PRADESH 
8789311383

pooja.ngr25@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K00-K95||Diseases of the digestive system, (2) ICD-10 Condition: K928||Other specified diseases of the digestive system, (3) ICD-10 Condition: K929||Disease of digestive system, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Ultrasound guided Erector Spinae plane block using Dexmedetomidine as an adjuvant to Ropivacaine  0.2% Ropivacaine + Dexmedetomidine 0.5 mcg/kg (1ml) to a total volume of o.5 ml / kg on each side 
Comparator Agent  Ultrasound-guided Erector spinae plane block with ropivacaine and NaCl in Paediatric abdominal surgeries.   0.2% Ropivacaine + 1 ml of 0.9% NaCl to a total volume of 0.5 ml/kg on each side 
 
Inclusion Criteria  
Age From  2.00 Year(s)
Age To  10.00 Year(s)
Gender  Both 
Details  Consent of patient(>9yrs,parents/guardian
ASA grade 1& 2
Weight between 10 kg to 30 kg
Patients undergoing elective abdominal surgery under general anaesthesia 
 
ExclusionCriteria 
Details  No consent
Allergy history
Skin infection
Deranged blood clotting
Congenital abnormalities
Systemic diseases

 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Time to first rescue analgesic.  24 hrs 
 
Secondary Outcome  
Outcome  TimePoints 
1.Intraoperative & postoperative opioid requirement
2.Postoperative pain score using CHEOPS scale
3.intraoperative hemodynamic parameters
4.Effect on emergence delirium
5.Complications if any 
1o min, 30 min, 60 min postoperatively & hourly upto 4 hrs & 6 hourly upto 24 hrs postoperatively 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   30/06/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Adequate postoperative pain assessment in pediatric patients may significantly improve their comfort and quality of life. ESP block is an emergency regional anaesthetic technique with significant potential and clinical benefit. ESP block provides visceral as well as somatic analgesia, relieves acute as well as chronic pain and can be utilized for analgesia at cervical, thoracic and abdominal levels with minimal side effects. ESPB have opioid sparing effect in pediatric patients, even in major surgeries. Dexmedetomidine has been shown to increase the duration of postop analgesia when used as an adjuvant in various nerve blocks in pediatric patients. In addition, dexmedetomidine provides a stable hemodynamic parameters and reduces the incidence of emergence delirium in pediatric patients. Available literature highlights the utility of Dexmedetomidine in terms of better analgesia and hemodynamic parameters when used as an adjuvant with ESPB in adults. The present study is designed to evaluate the efficacy of Dexmedetomidine as an adjuvant to Ropivacaine in bilateral ESP block in pediatric abdominal surgeries.  
Close